Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance

Research output: Contribution to journalArticleAcademicpeer-review

60 Citations (Scopus)

Abstract

Protease activated receptor (PAR)-1 expression in tumor cells is associated with disease progression and overall survival in a variety of cancers of epithelial origin; however, the importance of PAR-1 in the tumor microenvironment remains unexplored. Utilizing an orthotopic pancreatic cancer model in which tumor cells are PAR-1 positive whereas stromal cells are PAR-1 negative, we show that PAR-1 expression in the microenvironment drives progression and induces chemoresistance of pancreatic cancer. PAR-1 enhances monocyte recruitment into the tumor microenvironment by regulating monocyte migration and fibroblast dependent chemokine production thereby inducing chemoresistance. Overall, our data identify a novel role of PAR-1 in the pancreatic tumor microenvironment and suggest that PAR-1 may be an attractive target to reduce drug resistance in pancreatic cancer
Original languageEnglish
Pages (from-to)2294-2304
JournalInternational journal of cancer. Journal international du cancer
Volume135
Issue number10
DOIs
Publication statusPublished - 2014

Cite this